bluebird bio, Inc. reported earnings results for the full year ended December 31, 2024. For the full year, the company reported revenue was USD 83.81 million compared to USD 29.5 million a year ago. Net loss was USD 240.72 million compared to USD 211.91 million a year ago. bluebird bio, Inc. reported earnings results for the full year ended December 31, 2024. For the full year, the company reported revenue was USD 83.81 million compared to USD 29.5 million a year ago. Net loss was USD 240.72 million compared to USD 211.91 million a year ago.